ATE510844T1 - Cycloalkylcarbonylaminosäure-derivat und herstellungsverfahren dafür - Google Patents

Cycloalkylcarbonylaminosäure-derivat und herstellungsverfahren dafür

Info

Publication number
ATE510844T1
ATE510844T1 AT07706500T AT07706500T ATE510844T1 AT E510844 T1 ATE510844 T1 AT E510844T1 AT 07706500 T AT07706500 T AT 07706500T AT 07706500 T AT07706500 T AT 07706500T AT E510844 T1 ATE510844 T1 AT E510844T1
Authority
AT
Austria
Prior art keywords
groups
acid derivative
cycloalkylcarbonylaminosic
production
cycloalkylcarbonylamino acid
Prior art date
Application number
AT07706500T
Other languages
English (en)
Inventor
Nobuo Kobayashi
Tsuneo Koji
Hisatomo Kunii
Original Assignee
Seikagaku Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seikagaku Kogyo Co Ltd filed Critical Seikagaku Kogyo Co Ltd
Application granted granted Critical
Publication of ATE510844T1 publication Critical patent/ATE510844T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Furan Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT07706500T 2006-01-11 2007-01-10 Cycloalkylcarbonylaminosäure-derivat und herstellungsverfahren dafür ATE510844T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2006003593 2006-01-11
JP2006343594A JP3975226B2 (ja) 2006-01-11 2006-12-20 シクロアルキルカルボニルアミノ酸誘導体及びその製造方法
PCT/JP2007/050153 WO2007080883A1 (ja) 2006-01-11 2007-01-10 シクロアルキルカルボニルアミノ酸誘導体及びその製造方法

Publications (1)

Publication Number Publication Date
ATE510844T1 true ATE510844T1 (de) 2011-06-15

Family

ID=38256288

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07706500T ATE510844T1 (de) 2006-01-11 2007-01-10 Cycloalkylcarbonylaminosäure-derivat und herstellungsverfahren dafür

Country Status (7)

Country Link
US (1) US8481725B2 (de)
EP (1) EP1972636B1 (de)
JP (1) JP3975226B2 (de)
AT (1) ATE510844T1 (de)
AU (1) AU2007205577B9 (de)
CA (1) CA2636761C (de)
WO (1) WO2007080883A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4012239B2 (ja) 2006-01-11 2007-11-21 生化学工業株式会社 オキサゾロン誘導体
JP4047365B2 (ja) * 2006-01-11 2008-02-13 生化学工業株式会社 シクロアルカンカルボキサミド誘導体及びその製造方法
ATE509941T1 (de) * 2006-01-11 2011-06-15 Seikagaku Kogyo Co Ltd Cycloalkylcarbonylaminosäureester-derivat und herstellungsverfahren dafür
WO2009132453A1 (en) * 2008-04-28 2009-11-05 Neuromed Pharmaceuticals Ltd. Cyclylamine derivatives as calcium channel blockers
TWI579260B (zh) * 2012-03-28 2017-04-21 拜耳智慧財產有限公司 用於製備順式－烷氧基－取代之螺環狀苯基乙醯基胺基酸酯及順式－烷氧基－取代之螺環狀１ｈ－吡咯啶－２，４－二酮衍生物之方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS231227B1 (en) 1982-10-01 1984-10-15 Evzen Kasafirek 2,5-pierazindion derivatives
ZA897515B (en) 1988-10-07 1990-06-27 Merrell Dow Pharma Novel peptidase inhibitors
JP2701932B2 (ja) 1989-04-10 1998-01-21 サントリー株式会社 タンパク質分解酵素阻害剤
JPH04202170A (ja) 1990-11-29 1992-07-22 Taisho Pharmaceut Co Ltd トリペプチド誘導体
EP0729972A1 (de) * 1995-02-28 1996-09-04 F. Hoffmann-La Roche Ag Tetrahydronaphthalin-Peptidderivate
JPH09165360A (ja) 1995-03-31 1997-06-24 Takeda Chem Ind Ltd システインプロテアーゼ阻害剤
US6162828A (en) * 1995-03-31 2000-12-19 Takeda Chemical Industries, Ltd. Cysteine protease inhibitor
EP0804180A4 (de) 1995-10-30 2001-09-05 Smithkline Beecham Corp Verfahren zur cathepsinhemmung
AU3359697A (en) 1996-07-08 1998-02-02 Yamanouchi Pharmaceutical Co., Ltd. Bone resorption inhibitors
IL138246A0 (en) 1998-04-23 2001-10-31 Novartis Ag Certain thiol inhibitors of endothelin-converting enzyme
DE69923676T2 (de) 1998-04-23 2006-01-12 Novartis Ag Bestimmte heteroaryl substituierte thiol inhibitoren von endothelin wechselnden enzymen
JP3892187B2 (ja) 1998-11-12 2007-03-14 生化学工業株式会社 環状アミド誘導体
US6117870A (en) * 1998-11-12 2000-09-12 Fujirebio Kabushiki Kaisha Cyclic amide derivatives
JP2003524614A (ja) * 1998-12-22 2003-08-19 田辺製薬株式会社 α４β１媒介細胞接着のインヒビター
JP2001139534A (ja) 1999-11-16 2001-05-22 Yoshimitsu Nagao バリン誘導体およびその用途
GB0003111D0 (en) * 2000-02-10 2000-03-29 Novartis Ag Organic compounds
SV2003000617A (es) * 2000-08-31 2003-01-13 Lilly Co Eli Inhibidores de la proteasa peptidomimetica ref. x-14912m
AU2002258794A1 (en) * 2001-04-10 2003-10-20 Transtech Pharma, Inc. Probes, systems and methods for drug discovery
PT1430045E (pt) 2001-09-21 2007-01-31 Novartis Ag Derivados de pirano como inibidores de ace e nep
JP4202170B2 (ja) 2003-03-28 2008-12-24 三菱電機株式会社 空気調和装置
US20050192279A1 (en) * 2004-02-10 2005-09-01 Kent Barbay Pyridazinones as antagonists of alpha4 integrins
JP4047365B2 (ja) * 2006-01-11 2008-02-13 生化学工業株式会社 シクロアルカンカルボキサミド誘導体及びその製造方法
ATE509941T1 (de) * 2006-01-11 2011-06-15 Seikagaku Kogyo Co Ltd Cycloalkylcarbonylaminosäureester-derivat und herstellungsverfahren dafür

Also Published As

Publication number Publication date
AU2007205577B9 (en) 2013-02-28
EP1972636B1 (de) 2011-05-25
WO2007080883A1 (ja) 2007-07-19
US8481725B2 (en) 2013-07-09
CA2636761C (en) 2014-04-15
JP2007210998A (ja) 2007-08-23
AU2007205577A1 (en) 2007-07-19
US20090111983A1 (en) 2009-04-30
EP1972636A1 (de) 2008-09-24
EP1972636A4 (de) 2009-07-22
JP3975226B2 (ja) 2007-09-12
AU2007205577B2 (en) 2013-02-07
CA2636761A1 (en) 2007-07-19

Similar Documents

Publication Publication Date Title
ATE509941T1 (de) Cycloalkylcarbonylaminosäureester-derivat und herstellungsverfahren dafür
GB0601744D0 (en) Organic compounds
AU2008245082A8 (en) Aminodihydrothiazine derivatives substituted with a cyclic group
EP1541561A4 (de) Pyrazolderivate und verfahren zu deren herstellung
MX2010008361A (es) Derivados de arilamida oxazepinopirimidona sustituidos.
GB0719180D0 (en) New process
DK1740584T3 (da) Kondenseret chinolinderivat og anvendelse deraf
MX2009010837A (es) Nuevos compuestos heterociclicos nitrogenados, su preparacion y su utilizacion como medicamentos antibacterianos.
ATE517869T1 (de) Herstellung substituierter morphinan-6-one und salzen und zwischenprodukten davon
ATE510844T1 (de) Cycloalkylcarbonylaminosäure-derivat und herstellungsverfahren dafür
ATE448230T1 (de) Für die behandlung von obesitas geeignete tricyclische amidderivate
MX2010008360A (es) Derivados de oxazepinopirimidona heteroarilamida sustituidos.
NO20071319L (no) Fremgangsmate for fremstilling av isotiazolderivater.
EA200900797A1 (ru) Способ синтеза производных 3-аминотетрагидрофуран-3-карбоновой кислоты и их применение в качестве лекарственных средств
MXPA03011682A (es) Derivados sustituidos de n-acil -anilina, su preparacion y su uso como medicamento.
MY156304A (en) 5-hydroxymethyl-oxazolidin-2-one derivatives for treating bacterial intestinal diseases
TW200738693A (en) Substituted biaryls, process for their manufacture and use thereof as medicaments
WO2009019815A1 (ja) 新規γセクレターゼ阻害剤
EA201270360A1 (ru) Терапевтическое средство от тревожных расстройств
IL186832A0 (en) Process for the preparation of a carboxamide derivatives
TW200740798A (en) Substituted amides, process for their manufacture and use thereof as medicaments
WO2009034028A3 (de) Neue verbindungen
EP1908752A4 (de) Neue 2-chinolonderivate
EP1589023A4 (de) Oligosaccharidderivat
EP2177512A4 (de) Hemmer der s1p1-bindung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties